Financing
Payment of Deferred Purchase Consideration
Elevance Health Payment of Deferred Purchase Consideration decreased by 125.0% to -$3.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 78.6%, from -$14.00M to -$3.00M. Over 2 years (FY 2022 to FY 2025), Payment of Deferred Purchase Consideration shows a downward trend with a -26.7% CAGR.
Analysis
StatementCash Flow Statement
SectionFinancing
First reportedQ1 2018
Last reportedQ1 2026Apr 22, 2026
Metric ID:
isrg_payment_of_deferred_purchase_considerationHistorical Data
17 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $19.00M | $5.00M | $5.00M | $6.00M | $25.00M | $2.00M | $3.00M | $0.00 | $2.00M | $4.00M | $4.00M | $1.00M | -$14.00M | $3.00M | $21.00M | $12.00M | -$3.00M |
| QoQ Change | — | -73.7% | +0.0% | +20.0% | +316.7% | -92.0% | +50.0% | -100.0% | — | +100.0% | +0.0% | -75.0% | <-999% | +121.4% | +600.0% | -42.9% | -125.0% |
| YoY Change | — | — | — | — | +31.6% | -60.0% | -40.0% | -100.0% | -92.0% | +100.0% | +33.3% | — | -450.0% | -25.0% | >999% | — | +78.6% |
Range-$14.00M – $25.00M
CAGR-37.0%
Avg YoY Growth+134.2%
Median YoY Growth-25.0%
Current Streak2 quarters decline
Payment of Deferred Purchase Consideration at Other Companies
Frequently Asked Questions
- What is Elevance Health's payment of deferred purchase consideration?
- Elevance Health (ELV) reported payment of deferred purchase consideration of -$3.00M in Q1 2026.
- How has Elevance Health's payment of deferred purchase consideration changed year-over-year?
- Elevance Health's payment of deferred purchase consideration increased by 78.6% year-over-year, from -$14.00M to -$3.00M.
- What is the long-term trend for Elevance Health's payment of deferred purchase consideration?
- Over 2 years (2022 to 2025), Elevance Health's payment of deferred purchase consideration has grown at a -26.7% compound annual growth rate (CAGR), from $41.00M to $22.00M.